Mississippi - Session 2026
Title: Opioid drugs; prescriber shall discuss with patient before prescribing, the risks of the drugs and available alternatives.
AN ACT TO AMEND SECTION 41-29-137, MISSISSIPPI CODE OF 1972, TO REQUIRE THE PRESCRIBER OF A SCHEDULE II CONTROLLED SUBSTANCE OR ANY OTHER OPIOID DRUG, BEFORE ISSUING THE INITIAL PRESCRIPTION IN A COURSE OF TREATMENT FOR ACUTE OR CHRONIC PAIN AND AGAIN BEFORE ISSUING THE THIRD PRESCRIPTION OF THE COURSE OF TREATMENT, TO DISCUSS WITH THE PATIENT THE RISKS ASSOCIATED WITH THE DRUG BEING PRESCRIBED AND ALTERNATIVE TREATMENTS THAT MAY BE AVAILABLE; AND FOR RELATED PURPOSES.
| Date | Event | Detail |
|---|---|---|
| 2026-01-16 | Introduced | Bill introduced |
| 2026-02-03 | Status | failed |
| 2026-02-03 | Latest Action | (H) Died In Committee |
| Bill | Title | Status |
|---|---|---|
| SB 2726 | Mississippi Opioid Settlement Fund Advisory Council; to amend provisions related to. | enrolled |
| HB 1760 | Opioid Settlement Fund and Advisory Council; bring forward sections creating. | failed |
| HB 1152 | Right to Try Medical Cannabis Act; create. | vetoed |
| HB 895 | Medical cannabis; eliminate mandatory follow-up visit and extend validity periods of certification and ID cards to 24 months. | vetoed |
| HB 314 | Ibogaine; authorize SDH to select a consortium to conduct a drug development clinical trial with, to secure FDA's approval of. | enacted |
| HB 1034 | Compassionate Access to Medical Cannabis Act; create to allow terminally ill to use in hospitals. | failed |
| HB 513 | Public Health Trust Fund; divert a certain percentage of funds collected under the Medical Cannabis Act into for 4 years. | failed |
| SB 3318 | General Fund; FY2027 appropriation to University of Mississippi for the Center for Mississippi Medical Cannabis Research. | failed |